{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:53:53Z","timestamp":1793404433890,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1245\/s10434-022-12933-y","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:03:46Z","timestamp":1670601826000},"page":"2486-2493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-9454","authenticated-orcid":false,"given":"Christopher W.","family":"Mangieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian D.","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian B.","family":"Solsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Erali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Votanopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"5","key":"12933_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jso.23749","volume":"110","author":"S Ahmed","year":"2014","unstructured":"Ahmed S, et al. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis. J Surg Oncol. 2014;110(5):575\u201384.","journal-title":"J Surg Oncol."},{"issue":"3","key":"12933_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1245\/s10434-016-5712-3","volume":"24","author":"K Waite","year":"2017","unstructured":"Waite K, Youssef H. The role of neoadjuvant and adjuvant systemic chemotherapy with cytoreductive surgery and heated intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review. Annal Surg Oncol. 2017;24(3):705\u201320.","journal-title":"Annal Surg Oncol"},{"key":"12933_CR3","unstructured":"Mangieri NAT HIPEC PAPER ASO"},{"issue":"3","key":"12933_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/jso.25967","volume":"122","author":"JC Chen","year":"2020","unstructured":"Chen JC, et al. Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer. J Surg Oncol. 2020;122(3):388\u201398.","journal-title":"J Surg Oncol"},{"issue":"13","key":"12933_CR5","doi-asserted-by":"publisher","first-page":"9098","DOI":"10.1245\/s10434-021-10193-w","volume":"28","author":"A Bhatt","year":"2021","unstructured":"Bhatt A, et al. HIPEC methodology and regimens: the need for an expert consensus. Annal Surg Oncol. 2021;28(13):9098\u2013113.","journal-title":"Annal Surg Oncol"},{"issue":"3","key":"12933_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30(3):263.","journal-title":"J Clin Oncol"},{"key":"12933_CR7","volume-title":"Peritoneal carcinomatosis: drugs and diseases","author":"V Fern\u00e1ndez-Trigo","year":"1996","unstructured":"Fern\u00e1ndez-Trigo V, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH. Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C. In: PH Sugarbaker, editor. Peritoneal carcinomatosis: drugs and diseases. Springer; 1996."},{"issue":"214","key":"12933_CR8","first-page":"18","volume":"24","author":"AJ Witkamp","year":"1998","unstructured":"Witkamp AJ, van Coevorden F, Kaag MM, van Slooten GW, Beijnen JB, Boot H. Dose finding study of hyperthermic intraperitoneal chemotherapy with mitomycin C in patients with carcinosis of colorectal origin. Eur J Surg Oncol. 1998;24(214):18.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"12933_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00280-010-1460-4","volume":"68","author":"K Van der Speeten","year":"2011","unstructured":"Van der Speeten K, Stuart OA, Chang D, Mahteme H, Sugarbaker PH. Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis. Cancer Chemother Pharmacol. 2011;68(1):147\u201356.","journal-title":"Cancer Chemother Pharmacol"},{"key":"12933_CR10","doi-asserted-by":"publisher","first-page":"978394","DOI":"10.1155\/2013\/978394","volume":"2013","author":"Y Yonemura","year":"2013","unstructured":"Yonemura Y, Canbay E, Ishibashi H. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. Scientif World J. 2013;2013:978394.","journal-title":"Scientif World J"},{"issue":"4","key":"12933_CR11","first-page":"413","volume":"82","author":"MK Ibragimova","year":"2017","unstructured":"Ibragimova MK, Tsyganov MM, Litviakov NV. Natural and chemotherapy-induced clonal evolution of tumors. Biochem(Moscow). 2017;82(4):413\u201325.","journal-title":"Biochem(Moscow)."},{"issue":"1","key":"12933_CR12","first-page":"1","volume":"7","author":"JM Findlay","year":"2016","unstructured":"Findlay JM, et al. Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy. Nature Communi. 2016;7(1):1\u201313.","journal-title":"Nature Communi"},{"issue":"3","key":"12933_CR13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1245\/s10434-019-08064-6","volume":"27","author":"O Moaven","year":"2020","unstructured":"Moaven O, et al. Health-related quality of life after cytoreductive surgery\/HIPEC for mucinous appendiceal cancer: results of a multicenter randomized trial comparing oxaliplatin and mitomycin. Annal Surg Oncol. 2020;27(3):772\u201380.","journal-title":"Annal Surg Oncol"},{"issue":"29","key":"12933_CR14","doi-asserted-by":"publisher","first-page":"9775","DOI":"10.3748\/wjg.v20.i29.9775","volume":"20","author":"M Panczyk","year":"2014","unstructured":"Panczyk M. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J Gastroenterol. 2014;20(29):9775.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"12933_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","volume":"218","author":"EA Levine","year":"2014","unstructured":"Levine EA, Stewart JH IV, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surgeons. 2014;218(4):573\u201385.","journal-title":"J Am Coll Surgeons."},{"issue":"5","key":"12933_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jso.23749","volume":"110","author":"S Ahmed","year":"2014","unstructured":"Ahmed S, Stewart JH, Shen P, Votanopoulos KI, Levine EA. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis. J Surg Oncol. 2014;110(5):575\u201384.","journal-title":"J Surg Oncol"},{"issue":"9","key":"12933_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bcp.2013.02.017","volume":"85","author":"M Rebucci","year":"2013","unstructured":"Rebucci M, Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol. 2013;85(9):1219\u201326.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"12933_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-5-78","volume":"5","author":"F Di Nicolantonio","year":"2005","unstructured":"Di Nicolantonio F, et al. Cancer cell adaptation to chemotherapy. BMC Cancer. 2005;5(1):1\u201316.","journal-title":"BMC Cancer"},{"key":"12933_CR19","doi-asserted-by":"publisher","first-page":"163284","DOI":"10.1155\/2012\/163284","volume":"2012","author":"L Bijelic","year":"2012","unstructured":"Bijelic L, et al. Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: impact on perioperative outcomes and short-term survival. Gastroenterol Res Pract. 2012;2012:163284.","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"12933_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, et al. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura Peritoneum. 2016;1(2):99\u2013107.","journal-title":"Pleura Peritoneum"},{"issue":"1","key":"12933_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28(1):63\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"12933_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1245\/s10434-017-6315-3","volume":"25","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos KI, et al. PCI is not predictive of survival after complete CRS\/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Annal Surg Oncol. 2018;25(3):674\u20138.","journal-title":"Annal Surg Oncol"},{"issue":"6","key":"12933_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/jso.23546","volume":"109","author":"D Hompes","year":"2014","unstructured":"Hompes D, et al. The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study. J Surg Oncol. 2014;109(6):527\u201332.","journal-title":"J Surg Oncol"},{"issue":"1","key":"12933_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejso.2016.09.015","volume":"43","author":"V Leung","year":"2017","unstructured":"Leung V, et al. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis. Eur J Surg Oncol. 2017;43(1):144\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"12933_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jso.23728","volume":"110","author":"A Prada-Villaverde","year":"2014","unstructured":"Prada-Villaverde A, et al. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014;110(7):779\u201385.","journal-title":"J Surg Oncol"},{"issue":"10","key":"12933_CR26","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00384-020-03702-y","volume":"35","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. Oxaliplatin versus mitomycin C in HIPEC for peritoneal metastasis from colorectal cancer: a systematic review and meta-analysis of comparative studies. Int J Colorectal Dis. 2020;35(10):1831\u20139.","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"12933_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology. 2021;22(2):256\u201366.","journal-title":"The Lancet Oncology."},{"issue":"4","key":"12933_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/00015458.2019.1610260","volume":"119","author":"G Liberale","year":"2019","unstructured":"Liberale G, Ameye L, Hendlisz A. PRODIGE 7 should be interpreted with caution. Acta Chirurgica Belgica. 2019;119(4):263\u20136.","journal-title":"Acta Chirurgica Belgica"},{"issue":"8","key":"12933_CR29","first-page":"3209","volume":"39","author":"RF Ozols","year":"1979","unstructured":"Ozols RF, Locker GY, Doroshow JH, Grotzinger KR, Myers CE, Young RC. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res. 1979;39(8):3209\u201314.","journal-title":"Cancer Res"},{"issue":"3","key":"12933_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00685503","volume":"28","author":"G Los","year":"1991","unstructured":"Los G, Verdegaal EM, Mutsaers PH, McVie JG. Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol. 1991;28(3):159\u201365.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"12933_CR31","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1002\/1097-0142(19921215)70:12<2754::AID-CNCR2820701205>3.0.CO;2-A","volume":"70","author":"S Fujimoto","year":"1992","unstructured":"Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mufoh T, et al. Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer. 1992;70(12):2754\u201360.","journal-title":"Cancer"},{"issue":"5","key":"12933_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000227211","volume":"50","author":"G Panteix","year":"1993","unstructured":"Panteix G, Guillaumont M, Cherpin L, Cuichard J, Gilly FN, Carry PY, et al. Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology. 1993;50(5):366\u201370.","journal-title":"Oncology"},{"issue":"1","key":"12933_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1245\/s10434-018-7008-2","volume":"26","author":"KI Votanopoulos","year":"2019","unstructured":"Votanopoulos KI, et al. Appendiceal cancer patient-specific tumor organoid model for predicting chemotherapy efficacy prior to initiation of treatment: a feasibility study. Annal Surg Oncol. 2019;26(1):139\u201347.","journal-title":"Annal Surg Oncol"},{"issue":"13","key":"12933_CR34","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1245\/s10434-020-08790-2","volume":"27","author":"SD Forsythe","year":"2020","unstructured":"Forsythe SD, et al. Personalized identification of optimal HIPEC perfusion protocol in patient-derived tumor organoid platform. Annal Surg Oncol. 2020;27(13):4950\u201360.","journal-title":"Annal Surg Oncol"},{"issue":"5","key":"12933_CR35","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S1470-2045(21)00088-7","volume":"22","author":"F Carboni","year":"2021","unstructured":"Carboni F, Valle M. Limitations of the PRODIGE 7 trial. Lancet Oncol. 2021;22(5):e176.","journal-title":"Lancet Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12933-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T10:04:29Z","timestamp":1679306669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12933-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["12933"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12933-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}